These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23184041)

  • 21. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
    Molero P; Ortuño F; Zalacain M; Patiño-García A
    Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of electrochemical biosensor systems for the detection of specific DNA sequences in PCR-amplified nucleic acids related to the catechol-O-methyltransferase Val108/158Met polymorphism based on intrinsic guanine signal.
    Ozkan-Ariksoysal D; Tezcanli B; Kosova B; Ozsoz M
    Anal Chem; 2008 Feb; 80(3):588-96. PubMed ID: 18181582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of association between genetic variants in COMT and schizophrenia: an update.
    Okochi T; Ikeda M; Kishi T; Kawashima K; Kinoshita Y; Kitajima T; Yamanouchi Y; Tomita M; Inada T; Ozaki N; Iwata N
    Schizophr Res; 2009 May; 110(1-3):140-8. PubMed ID: 19329282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of catechol-O-methyltransferase gene polymorphisms with schizophrenia and negative symptoms in a Chinese population.
    Li WJ; Kou CG; Yu Y; Sun S; Zhang X; Kosten TR; Zhang XY
    Am J Med Genet B Neuropsychiatr Genet; 2012 Jun; 159B(4):370-5. PubMed ID: 22354729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fetal Val108/158Met catechol-O-methyltransferase (COMT) polymorphism and placental COMT activity are associated with the development of preeclampsia.
    Pertegal M; Fenoy FJ; Hernández M; Mendiola J; Delgado JL; Bonacasa B; Corno A; López B; Bosch V; Hernández I
    Fertil Steril; 2016 Jan; 105(1):134-43.e1-3. PubMed ID: 26450530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential association of the COMT Val158Met polymorphism with clinical phenotypes in schizophrenia and bipolar disorder.
    Goghari VM; Sponheim SR
    Schizophr Res; 2008 Aug; 103(1-3):186-91. PubMed ID: 18571901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between catechol-O-methyl-transferase Val108/158Met polymorphism and suicide.
    Pivac N; Pregelj P; Nikolac M; Zupanc T; Nedic G; Muck Seler D; Videtic Paska A
    Genes Brain Behav; 2011 Jul; 10(5):565-9. PubMed ID: 21486391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of gender and catechol O-methyltransferase (COMT) Val108/158Met polymorphism on emotion regulation in velo-cardio-facial syndrome (22q11.2 deletion syndrome): An fMRI study.
    Coman IL; Gnirke MH; Middleton FA; Antshel KM; Fremont W; Higgins AM; Shprintzen RJ; Kates WR
    Neuroimage; 2010 Nov; 53(3):1043-50. PubMed ID: 20123031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms in catechol-O-methyltransferase and methylenetetrahydrofolate reductase in relation to the risk of schizophrenia.
    Muntjewerff JW; Gellekink H; den Heijer M; Hoogendoorn ML; Kahn RS; Sinke RJ; Blom HJ
    Eur Neuropsychopharmacol; 2008 Feb; 18(2):99-106. PubMed ID: 17716874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association study of a functional catechol-O-methyltransferase genetic polymorphism with age of onset, cognitive function, symptomatology and prognosis in chronic schizophrenia.
    Tsai SJ; Hong CJ; Liao DL; Lai IC; Liou YJ
    Neuropsychobiology; 2004; 49(4):196-200. PubMed ID: 15118357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sexually divergent effect of COMT Val/met genotype on subcortical volumes in schizophrenia.
    Bollettini I; Spangaro M; Poletti S; Lorenzi C; Pirovano A; Vai B; Smeraldi E; Cavallaro R; Benedetti F
    Brain Imaging Behav; 2018 Jun; 12(3):829-836. PubMed ID: 28667376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of the catechol-O-methyltransferase Val108/158Met polymorphism on the plasma concentration of catecholamine metabolites and on clinical features in type I bipolar disorder--a preliminary report.
    Dávila R; Zumárraga M; Basterreche N; Arrúe A; Zamalloa MI; Anguiano JB
    J Affect Disord; 2006 Jun; 92(2-3):277-81. PubMed ID: 16542735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association study between the rs165599 catechol-O-methyltransferase genetic polymorphism and schizophrenia in a Brazilian sample.
    Cordeiro Q; Silva RT; Vallada H
    Arq Neuropsiquiatr; 2012 Dec; 70(12):913-6. PubMed ID: 23295417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment.
    Chen CY; Yeh YW; Kuo SC; Ho PS; Liang CS; Yen CH; Lu RB; Huang SY
    Psychoneuroendocrinology; 2016 Mar; 65():67-75. PubMed ID: 26724569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The lack of association between catechol-O-methyl-transferase Val108/158Met polymorphism and smoking in schizophrenia and alcohol dependence.
    Nikolac M; Sagud M; Nedic G; Nenadic Sviglin K; Mihaljevic Peles A; Uzun S; Vuskan Cusa B; Kozumplik O; Zivkovic M; Mustapic M; Jakovljevic M; Pavlovic M; Muck-Seler D; Borovecki F; Pivac N
    Psychiatry Res; 2013 Jan; 205(1-2):179-80. PubMed ID: 22939231
    [No Abstract]   [Full Text] [Related]  

  • 37. The catechol O-methyltransferase Val158Met polymorphism is not associated with broad-based cognitive functioning in schizophrenia.
    Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Sullens A; Yolken RH
    Schizophr Res; 2007 Nov; 96(1-3):87-92. PubMed ID: 17601704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia--relationship with COMT Val¹⁰⁸/¹⁵⁸Met polymorphism, gender and symptomatology.
    Boot E; Booij J; Abeling N; Meijer J; da Silva Alves F; Zinkstok J; Baas F; Linszen D; van Amelsvoort T
    J Psychopharmacol; 2011 Jul; 25(7):888-95. PubMed ID: 21447540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COMT and STH polymorphisms interaction on cognition in schizophrenia.
    Bosia M; Pigoni A; Pirovano A; Lorenzi C; Spangaro M; Buonocore M; Bechi M; Cocchi F; Guglielmino C; Bramanti P; Smeraldi E; Cavallaro R
    Neurol Sci; 2015 Feb; 36(2):215-20. PubMed ID: 25283873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls.
    Mao C; Wang XW; Qiu LX; Liao RY; Ding H; Chen Q
    Breast Cancer Res Treat; 2010 Jun; 121(3):719-25. PubMed ID: 20464630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.